Pulmonx Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.7% | +9.3% | -5.4% | -6.0% | -21.8% | -5.4% | +43.5% | -38.3% | -6.1% | +38.5% | -30.6% | – | |
| – | -6.7% | +1.3% | +4.4% | -1.4% | -5.4% | +1.6% | +10.7% | -16.9% | -17.9% | -2.5% | -10.6% | – | |
| – | – | – | – | -37.1% | -4.4% | -706.2% | – | -102.7% | – | – | – | – | |
| – | -59.3% | +125.5% | +4.0% | -11.3% | -73.3% | +171.2% | -83.7% | +81.6% | -85.4% | -30.8% | -88.9% | – | |
| – | -379.1% | -9.0% | -66.7% | – | +108.4% | +16.0% | -66.5% | +59.2% | -100.1% | -30.8% | -88.9% | – | |
| – | – | +59.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | -97.9% | +5,000.0% | – | -103.0% | – | |
| – | -97.0% | +4,982.4% | -102.5% | – | -86.5% | +971.0% | -103.0% | – | -69.6% | +3,583.6% | -125.3% | – | |
| – | – | – | – | – | – | -51.9% | -75.0% | +18.8% | -726.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.